ResearcherUniversity of ToyamaNo recent work listed

Kohji Takagi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5095-6420; OpenAlex author ID A5012486358. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper

Papers 2

Interleukin-32 regulates downstream molecules and promotes the invasion of pancreatic cancer cells. Co-author DOI 10.3892/ol.2021.13132 ↗
Establishment of highly invasive pancreatic cancer cell lines and the expression of IL-32. Co-author DOI 10.3892/ol.2020.11825 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Takahiko Nakajima · 2 shared papers, 2020–2022 · strength 0.26
- Paper Interleukin-32 regulates downstream molecules and promotes the invasion of pancreatic cancer cells. DOI 10.3892/ol.2021.13132 ↗
- Paper Establishment of highly invasive pancreatic cancer cell lines and the expression of IL-32. DOI 10.3892/ol.2020.11825 ↗
Johji Imura · 2 shared papers, 2020–2022 · strength 0.26
- Paper Interleukin-32 regulates downstream molecules and promotes the invasion of pancreatic cancer cells. DOI 10.3892/ol.2021.13132 ↗
- Paper Establishment of highly invasive pancreatic cancer cell lines and the expression of IL-32. DOI 10.3892/ol.2020.11825 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.